Haemodynamic contributions to the pathogenesis of preeclampsia and eclampsia

Fetal and Maternal Medicine Review

Volumn 19, Issue 1, 2008, Pages 85-104

  Bernstein, Ira M ^a   Cipolla, Marilyn J ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE;

BRAIN CIRCULATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG EFFECT; ECLAMPSIA; HEMODYNAMICS; HUMAN; HYPERTENSION; MATERNAL HYPERTENSION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PLACENTAL DELIVERY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY TOXEMIA; PREPREGNANCY CARE; PROPHYLAXIS; PROTEINURIA; PUERPERIUM; RECURRENT DISEASE; REVIEW; SYMPATHETIC TONE; THROMBOCYTE ACTIVATION; UTERUS BLOOD FLOW;

EID: 43649093379     PISSN: 09655395     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0965539508002088     Document Type: Review

References (119)

1. Roberts JR. Preeclampsia: what we know and what we do not know. Seminar Perinatol 2000; 24: 24-28.
2. Maynard SE, Min JY, Merchan J, Lin KH, Li J, Mondai S et al. Excess placental soluble fms-like tyrosine kinase 1 (sflt1) may contribute to endothelial dysfunction, hypertension and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-58.
3. Levine R, Maynardm SE, Qian C, Lim K-H, England LJ, Yu KF et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-83.
4. Hubel CA. Oxidative stress and preeeclampsia. Fet Mat Med Rev 1997; 9: 73-101.
5. Roberts J, Hubel CA. Is oxidative stress the link in the two-stage model of preeclampsia. Lancet 1999; 354: 788-89.
6. Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Pre-eclampsia and fetal growth restriction: how morphometrically different is the placenta. Placenta 2006; 27: 727-34.
7. Meekins JW, Pijnnenborg R, Hanssens M, McFadyen IR, van Assche A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994: 101; 669-74.
8. Zhang P, Schmidt M, Cook L. Maternal vasculopathy and histologic diagnosis of preeclampsia: poor correlation of histological changes and clinical manifestation. Am J Obstet Gynecol 2006; 194: 1050-6.
9. Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet 2003; 189: 1173-77.
10. Donker RB, Molema G, Faas MM, Kallenberg GM, van Pampus MG, Timmer A et al. Absence of in vivo generalized pro-inflammatory endothelial activation in severe, early onset preeclampsia. J Soc Gynecol Invest 2005; 12: 518-28.
11. Xiong X, Frasier WD. Impact of pregnancy-induced hypertension on birth weight by gestational age. Paediatr Perinat 2004; 18: 186-91.
12. Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease? BJOG 2004; 111: 298-302.
13. Bernstein IM, Janowiak M, Thomas CS, Badger GJ. Birth weight shows a bimodal distribution in newborns of near term and term preeclamptic mothers. J Soc Gynecol Invest 2006; 13: 237A.
14. Bernstein IM, Meyer MC, Osol G, Ward K. Intolerance to volume expansion: A theorized mechanism for the development of preeclampsia. Obstet Gynecol 1998; 92: 306-308.
15. Campbell DM, MacGillivray I. Preeclampsia in twin pregnancies: incidence and outcome. Hypertension Pregn. 1999; 18: 197-207.
16. Sanchez-Torres F, Santamaria A. Histopathologia renal en la gestacion molar. Rev Obstet Ginecol Venezuela 1965; 25: 657-69.
17. Rovinsky JJ, Jaffin H. Cardiovascular hemodynamics in pregnancy I Blood and plasma volumes in multiple pregnancy. Am J Obstet Gynecol 1965: 93: 1-5
18. Pritchard JA. Blood volume changes in pregnancy and the puerperium; IV Anemia associated with hydatidiform mole. Am J Obstet Gynecol 1965; 91: 621-29.
19. French W, Freund U, Carlson R, Weil MH. High output cardiac failure associated with pulmonary edema complicating hydatidiform mole. Arch Int Med 1977; 137: 367-69.
20. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C et al. A molecular variant of angiotensinogen associated with preeclampsia. Nature Genetics 1993; 4: 59-61.
21. Jeunemaitre X, Soubrier YV, Kotelevtsev RP, Lifton CS, Williams RR, Charru A et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-80.
22. Bernstein IM, Ziegler W, Stirewalt WS, Brumsted J, Ward K. Angiotensinogen genotype and plasma volume in nulligravid women. Obstet Gynecol 1998; 92: 171-73.
23. Easterling TR, Benedetti TJ, Schmucker BC, Millard SP. Maternal hemodynamics in normal and preeclamptic pregnancies: A longitudinal study. Obstet Gynecol 1990; 76: 1061-69.
24. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmeider RE. Preeclampsia-a state of sympathetic overactivity. N Engl J Med 1996; 335: 1480-85.
25. Julius S, Pascual AV, Reilly K, London R. Abnormalities of plasma volume in borderline hypertension. Arch Intern Med 1971; 127: 116-19.
26. Ellis CN, Julius S. Role of central blood volume in hyperkinetic borderline hypertension. Br Heart J 1973; 35: 450-55.
27. Clapp JF, Capeless EL. Cardiovascular function before, during, and after the first and subsequent pregnancies. Am J Cardiol 1997; 80: 1469-73.
28. Bernstein IM, Shapiro R, Whitsel A, Schonberg A. Relationship of plasma volume to sympathetic tone in nulliparous women. Am J Obstet Gynecol 2003; 188: 938-42.
29. Denq JC, O'Brien PC, Low PA. Normative data on phases of the Valsalva maneuver. J Clinical Neurophys 1998; 15: 535-40.
30. Sandroni P, Novak V, Opfer-Gehrking TL, Huck CA, Low PA. Mechanisms of blood pressure alterations in response to the Valsalva maneuver in postural tachycardia syndrome. Clin Autonomic Res 2000; 10: 1-5.
31. Courtar DA, Spaanderman MEA, Aardenburg R, Janssen BJA, Peeters LLH. Low plasma volume coincides with sympathetic hyperactivity and reduced baroreflex sensitivity in formerly preeclamptic patients. J Soc Gynecol Invest 2006; 13: 48-52.
32. Damron D, Bouchard B, Shapiro R, Schonberg A, Bernstein IM. Platelet activation, sympathetic tone and plasma volume in nulligravid women of reproductive age. Obstet Gynecol 2004; 103: 931-36.
33. Janes SL, Kyle PM, Redman C, Goodall AH. Flow cytometric detection of activated platelets in pregnant women prior to the development of preeclampsia. Thromb Haemost 1995; 74: 1059-63.
34. Konijnenber A, Van Der Post JA, Mol BW, Schaap MCL, Lazarov R, Bleker OP et al. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study. Am J Obstet Gynecol 1997; 177: 434-42.
35. McCrae KR, Samuels P, Schreiber AD. Pregnancy-associated thrombocytopenia: pathogenesis and management. Blood 1992; 80: 2697-714.
36. Kupferminc MJ, Peaceman AM, Aderka D, Wallach D, Socol ML. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996; 88: 420-27.
37. Benyo DF, Smarason A, Redman CWG, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001; 86: 2505-12.
38. Tjoa ML, van Vogt JMG, Blankenstein MA, Oudejans CBM, van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol 2003; 59: 29-37.
39. Damron D, Sallam R, Bernstein IM, Shapiro R, Schonberg A. Markers of inflammation and sympathetic tone in nulligravid women. Am J Obstet Gynecol 2003; 89: S85A.
40. Aardenburg R, Spaanderman MEA, Ekhart TH, van Eijndhoven HW, Van Der Heijden OWH, Peeters LLH. Low plasma volume following pregnancy complicated by preeclampsia predisposes for hypertensive disease in a next pregnancy. BJOG 2003; 110: 1001-1006.
41. Eguchi K, Ogun N, Sawai T, Yonezawa M. Comparison of plasma concentrations of arginine vasopressin (AVP) and atrial natriuretic peptide (ANP) in normal and preeclamptic pregnancies. J Perinatal Med 1996; 24: 437-43.
42. Spaanderman MEA, Ekhart THA, de Leeuw PW, Peeters LLH. Angiotensin II sensitivity in nonpregnant formerly preeclamptic women and healthy parous controls. J Soc Gynecol Invest 2004; 11: 416-22.
43. Aardenburg R, Spaanderman MEA, van Eijndhoven HW, de Leeuw PW, Peeters LLH. A low plasma volume in formerly preeclamptic women predisposes to the recurrence of hypertensive complications in the next pregnancy. J Soc Gynecol Invest 2006; 13: 598-603.
44. Naden RP, Rosenfeld CR. Modulation of the uteroplacental circulation: renin-angiotensin and adrenergic systems. In: Rosenfeld CR (ed) Reproductive and Perinatal Medicine, Ithaca, NY: Perinatology Press, 1989, 207-38.
45. Magness RR, Rosenfeld CR. Systemic and uterine responses to alpha-adrenergic stimulation in pregnant and nonpregnant ewes. Am J Obstet Gynecol 1986; 155: 897-904.
46. D'Angelo G, Osol G. Regional variation in resistance artery diameter responses to alpha-adrenergic stimulation during pregnancy. Am J Physiol 1993; 264: H78-H85.
47. Damron D, Bernstein IM, Shapiro R, Schonberg A. Uterine Blood Flow Response to Alpha-Adrenergic Blockade in Nulligravid Women of Reproductive Age. J Soc Gynecol Invest 2004; 11: 388-92.
48. Zuspan FP. Catecholamines: Their role in pregnancy and the development of pregnancy-induced hypertension. J Reprod Med 1979; 23: 143-50.
49. Tunbridge RDG, Donnai P. Plasma noradrenaline in normal pregnancy and hypertension of late pregnancy. Br J Obstet Gynecol 1981; 88: 105-108.
50. Davey DA, Macnab MF. Plasma adrenaline, noradrenaline, and dopamine in pregnancy hypertension. Br J Obstet Gynecol 1981; 88: 611-18.
51. Yang CC, Chao TC, Kuo TB, Yin CS, Chen HI. Preeclamptic pregnancy is associated with increased sympathetic and decreased parasympathetic control of HR. Am J Physiol Circ Physiol 2000; 278: H1269-73.
52. Soghomonians A, Barakat AI, Thirkill TL, Douglas GC. Trophoblast migration under flow is regulated by endothelial cells. Biol Reprod 2005; 73: 14-19.
53. Magness RR, Grindle KM, Balanza E, Echalar L, Varags E, Zamudio S. Uterine artery shear stress in pregnancy: Altitude, ethnic ancestry and preeclampsia. Reprod Sci 2007; 14: 11A abstract 190.
54. Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341: 1447-454.
55. Barron WM. Hypertension. In: Medical Disorders of Pregnancy. Barron WM, Lindheimer M, (eds) Mosby Year Book, St. Louis, 1991; 1-41.
56. Villar MA, Sibai BM. Eclampsia. In: Arias F, (ed) Obstetrics and Gynecology clinics of North America. High Risk Pregnancy, vol. 15 Philadelphia: WB Saunders, 1988; 356-77.
57. Easton DJ. Severe preeclampsia/eclampsia hypertensive encephalopathy of pregnancy? Cerebrovasc Dis 1998; 8: 53-58.
58. Zunker P, Happe S. Georgiadis AL, Louwen F, Georgiadis D, Ringelstein EB et al. Maternal cerebral hemodynamics in pregnancy-related hypertension. A prospective transcranial Doppler study. Ultrasound Obstet Gynecol 2000; 16: 179-87.
59. Thomas SV. Neurologic aspects of eclampsia. J Neurol Sci 1998; 155: 37-43.
60. Donaldson JO. The brain in eclampsia. Hypertens Pregnancy 1994; 13: 115-33.
61. Cipolla MJ. Brief review: Cerebrovascular function during pregnancy and eclampsia. Hypertension 2007; 50: 14-24.
62. Williams KP, Wilson S. Persistence of cerebral hemodynamic changes in patients with eclampsia: A report of three cases. Am J Obstet Gynecol 1999; 181: 1162-165.
63. Richards AM, Moodley J, Graham DI, Bullock MR. Active management of the unconscious eclamptic patient. Br J Obstet Gynecol 1986; 93: 554-62.
64. Richards AM, Graham DI, Bullock MR. Clinical pathological study of neurological complications due to hypertensive disorders of pregnancy. J Neurol Neurosurg Psychiatr 1988; 51: 416-21.
65. Schwartz RB, Jones KM, Kalina P, Gajakian RL, Mantello MT, Garada B et al. Hypertensive encephalopathy: findings on CT, MR-Imaging, and SPECT-Imaging in 14 cases. Am J Radiol 1992; 159: 379-83.
66. Kanki T, Tsukimori K, Mihara F, Nakano H. Diffusion-weighted images and vasogenic edema in eclampsia. Obstet Gynecol 1999; 93: 821-23.
67. Manfredi M, Beltramello A, Bongiovanni LG, Polo A, Pistoia L, Rizzuto N. Eclamptic encephalopathy: imaging and pathogenetic considerations. Acta Neurol Scand 1997; 96: 277-82.
68. Koch S, Rabinstein A, Falcone S, Forteza A. Diffusion-weighted imaging shows cytotoxic and vasogenic edema in eclampsia. Am J Neurorad 2001; 22: 1068-1070.
69. Mas J-L, Lamy C. Stroke in pregnancy and the postpartum period. In: MD Ginsberg MD, Bogousslavsky J (eds) Cerebrovascular Disease: Pathophysiology, Diagnosis and Management. Blackwell Science, Malden, MA, 2004, Vol. II, Ch. 119.
70. Port JD, Beauchamp NJ. Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics 1998; 18: 253-67.
71. Digre KB, Varner MW, Osborn AG, Crawford S. Cranial magnetic resonance imaging in severe preeclapmsia vs. eclampsia. Arch Neurol 1993; 50: 399-406.
72. Schafer PW, Buonnano FS, Gonzalez RG, Schwamm LH. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in patients with eclampsia. Stroke 1997; 28: 1082-1085.
73. Schwartz RB, Mulern RV, Grudbjartsson H, Jolesz F. Diffusion-weighted imaging in hypertensive encephalopathy: clues to pathogenesis. Am J Neuroradiol 1998; 19: 859-62.
74. Shah AK, Whitty JE. Brain MRI in periperum seizures: usefulness of combined T2 and diffusion-weighted MR imaging. J Neurol Sci 1999; 166: 122-25.
75. Pizon AF, Wolfson AB. Postpartum focal neurologic deficits: Posterior leukoencephalopathy syndrome. J Emergency Med 2005; 29: 163-66.
76. Servillo G, Striano P, Striano S. Posterior reversible encephalopathy syndrome (PRES) in obstetric critically ill patients. Intensive Care Med 2003; 29: 2323-326.
77. Rapoport SI. Brain edema and the blood-brain barrier. In: Welch KMA, Caplan LR, Reis DJ, Siesjo BK, Weir B (eds) Primer on Cerebrovascular Disease. Academic Press, San Diego, 1997; 25-28.
78. Ishii S, Koike J, Hatashita. In: Mizukami M et al. (eds) Hypertensive Intracranial Hemorrhage. Brain edema in hypertensive intracranial hemorrhage. Raven Press, New York, 1983; 118-35.
79. Johansson B, Li C-L, Olsson Y, Klatzo I. Effect of acute arterial hypertension on the blood-brain barrier to protein tracers. Acta Neuropath 1970; 16: 117-24.
80. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A et al. A reversible posterior encephalopathy syndrome. N Engl J Med 1996; 334: 494-500.
81. Iannotti F, Hoff JT, Schielke GP. Brain tissue pressure in focal cerebral ischemia. J Neurosurg 1985; 62: 83-89.
82. Zeeman GG, Fleckenstein J, Twickler DM, Cunningham FG. Cerebral infarction in eclampsia. Am J Obstet Gynecol 2004; 190: 714-20.
83. Rapoport SI. In: Welch KMA, Caplan LR, Reis DJ, Siesjo BK, Weir B (eds) Brain edema and the blood-brain barrier. Primer on cerebrovascular disease. Academic Press, San Diego, 1997; 25-28.
84. Donaldson JO. In: Donaldson JO (ed.) Eclampsia. Neurology of pregnancy. London: WB Saunders, 1989; 269-310.
85. Mackey K, Meyer MC, Stirewalt WS, Starcher BC, McLaughlin MK. Composition and mechanics of mesenteric resistance arteries from pregnant rats. Am J Physiol 1992; 263: R2-8.
86. Hermsteiner M, Zoltan DR, Kunzel W. The vasoconstrictor response of uterine and mesenteric resistance arteries is differentially altered in the course of pregnancy. Eur J Obstet Gynecol Reprod Biol 2001; 100: 29-35.
87. Cipolla M, Osol G. Hypertrophic and hyperplastic effects of pregnancy on the uterine arterial wall. Am J Obstet Gynecol 1994; 171: 805-11.
88. Gilson GJ, Mosher MD, Conrad KP. Systemic hemodynamics and oxygen transport during pregnancy in chronically instrumented, conscious rats. Am J Physiol 1992; 263: H1911-H1918.
89. Euser AG, Cipolla MJ. Cerebral blood flow autoregulation and edema formation during pregnancy in anesthetized rats. Hypertension 2007; 49: 334-40.
90. Cipolla MJ, Vitullo L, McKinnon J. Cerebral artery reactivity changes during pregnancy and postpartum: a role in eclampsia? Am J Physiol 2004; 286: H2127-H2132.
91. Sabai BM. Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990; 163: 1049-55.
92. Mattar F, Sabai BM. Eclampsia. VIII. Risk factors for maternal mortality. Am J Obstet Gynecol 2000; 182: 307-12.
93. Douglas KA, Redman CWG. Eclampsia in the United Kingdom. Br Med J 1994; 309: 1395-1400.
94. Sadoshima S, Busija DW, Heistad DD. Mechanisms of protection against stroke in stroke-prone spontaneously hypertensive rats. Am J Physiol 1983; 244: H406-H412.
95. Cipolla MJ, Bullinger LV. Pregnancy decreases cerebrovascular resistance and increases blood-brain barrier permeability during acute hypertension: Role in eclampsia? Reprod Sci 2008; (In press).
96. Baumbach GL, Dobrin PB, Hart MN, Heistad DD. Mechanics of cerebral arterioles in hypertensive rats. Circ Res 1988; 62: 56-64.
97. Heistad DD, Baumbach GL. Cerebral vascular changes during chronic hypertension: good guys and bad guys. J Hypertens 1992; 10: S71-S75.
98. Baumbach GL, Heistad DD. Cerebral circulation in chronic arterial hypertension. Hypertension 1988; 12: 89-95.
99. Chillon J-M, Ghoniem S, Baumbach GL. Effects of chronic nitric oxide synthase inhibition on cerebral arterioles in rats. Hypertension 1997; 30: 1097-104.
100. Morreau P, Takase H, Kung CF, van Rooijen M, Schaffner T, Luscher TF. Structure and function of the rat basilar artery during chronic nitric oxide synthase inhibition. Stroke 1995; 26: 1922-929.
101. Werber AH, Heistad DD. Effects of chronic hypertension and sympathetic nerves on the cerebral microvasculature of stroke-prone spontaneously hypertensive rats. Circ Res 1984; 55: 268-94.
102. Cipolla MJ, DeLance N, Vitullo L. Pregnancy prevents hypertensive remodeling of cerebral arteries: A potential role in the development of eclampsia. Hypertension 2006; 47: 619-26.
103. Aukes AM, Vitullo L, Zeeman GG, Cipolla MJ. Pregnancy prevents hypertensive remodeling and decreases myogenic reactivity in posterior cerebral arteries from Dahl salt-sensitive rats: A role in eclampsia? Am J Physiol 2007; 292: H1071-1076.
104. Cipolla MJ, Smith J, Bishop N, Bullinger LV, Godfrey JA. Pregnancy reverses hypertensive remodeling of cerebral arteries. Hypertension 2008; 51: 1-6.
105. Cipolla MJ, Vitullo L, DeLance N, Hammer E. The cerebral endothelium during pregnancy: A potential role in the development of eclampsia. Endothelium 2005; 12: 1-5.
106. Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998; 92: 883-89.
107. Belfort MA, Moise Jr. KJ. Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study. Am J Obstet Gynecol 1992; 167: 661-66.
108. Euser AG, Bullinger LV, Cipolla MJ. Magnesium sulfate decreases blood-brain barrier permeability during acute hypertension in pregnant rats. Exp Physiol 2008; 93: 254-61.
109. Bernstein IM, Thibault A, Mongeon J, Badger GJ. The effect of pregnancy on arterial compliance. Obstet Gynecol 2005; 105: 621-25.
110. Skhaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. N Engl J Med 2002; 346: 33-38.
111. Basso O, Christensen K, Olsen J. Higher risk of preeclampsia after change of partner. An effect of longer interpregnancy intervals. Epidemiology 2001; 12: 624-29.
112. Li DK, Wi S. Changing paternity and the risk of preeclampisa/eclampsia in the subsequent pregnancy. Am J Epidemiol 2000; 151: 57-62.
113. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 353: 785-99.
114. Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995; 74: 772-76.
115. Irgens HU, Reisaeter L, Irgens LM, Rie RT. Long-term mortality of mothers and father after preeclampsia:populations based cohort study. BMJ 2001; 323: 1213-217.
116. Funai EF, Friedlander Y, Paltiel O, Tiram E, Xue X, Deutsch L et al. Long-term mortality after preeclampsia. Epidemiology 2005; 16: 206-15.
117. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, c-reactive protein, albumin, or leukocyte count with coronary artery disease: Meta-analyses of prospective studies. JAMA 1998; 279; 18: 1477-482.
118. Kamat SG, Kleiman NS. Platelets and platelet inhibitors in acute myocardial infarction. Cardiology Clin 1995; 13: 435-47.
119. Julius S, Majahalme S. The changing face of sympathetic overactivity in hypertension. Ann Med 2000; 32: 365-70.